ESC 365 - Stopping anticoagulation in VTE. Is there a risk?

ESC Premium Access

Stopping anticoagulation in VTE. Is there a risk?

Session: The chronic risk of venous thrombosis: tailoring extended prevention with NOACs

Topic: Prevention

Speaker: Professor S. Middeldorp (Amsterdam, NL)

Sponsored by Bayer AG

Event: ESC Congress 2019

Congress Presentation

About the speaker

Professor Saskia Middeldorp

Amsterdam UMC - Location VUmc, Amsterdam (Netherlands (The))

3 presentations

0 follower

2 more presentations in this session

How evidence will change practice: VTE guideline recommendation in focus

Speaker: Professor S. Konstantinides (Mainz, DE)

The chronic risk of venous thrombosis - Discussion

Speaker: Professor S. Konstantinides (Mainz, DE) Professor S. Middeldorp (Amsterdam, NL)

Access the full session

The chronic risk of venous thrombosis: tailoring extended prevention with NOACs

Speakers: Professor S. Middeldorp, Professor S. Konstantinides, Professor S. Konstantinides, Professor S. Middeldorp

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by